Antipsychotic medicine Risperdal (Risperidone) is indicated for the treatment of schizophrenia disease that is characterized by hallucinations, delusions and social withdrawal and for the short term treatment of bipolar manic depression, from what more than three million Americans believed to suffer.
It has been known that physicians now have expanded two [...]
Seroquel medication is an approved medicine for bipolar disorder and schizophrenia medication. However, Seroquel drug is not approved for treatment of patients with dementia-related psychosis. Since its approval in 1997, SEROQUEL has had over 8 million patient exposures worldwide.
The results of a safety investigation, which assessed the risk of [...]
The following safety information is necessary for those who prescribes or is prescribed to take generic Risperdal as antipsychotic medication.
First of all, Risperdal (Risperidone) is not approved for the treatment of patients with Dementia-Related Psychosis. Such elderly patients treated with atypical antipsychotic drugs are at an increased risk of death.
Second, Risperdal [...]
ABILIFY (Aripiprazole) drug was developed by two companies: Otsuka Pharmaceutical Co., Ltd and Bristol-Myers Squibb Company. In 2004 Abilify medicine was approved in for treating schizophrenia disease and in 2008 it was ratified as medicine for bipolar disorder.
It has been known today that the U.S. Food and Drug Administration (FDA) [...]
Professor Eduard Vieta, Clinical Institute of Neuroscience, University of Barcelona, Spain suggests that bipolar disorder is considered to be a chronic, lifelong illness. Patients can become depressed or manic. And it is generally agreed that maintenance therapy is important and can give long-term relief from the relapses.
The data from [...]
Abilify drug was generally approved in 2004 for treating schizophrenia disease and this medicine was supposed to be used in treating bipolar disorder. Indeed, on April 8, 2008, the European Commission allowed Abilify medication (Aripiprazole) to be marketed for patients with Bipolar I Disorder.
Such kind of disease as Bipolar I Disorder contains [...]
According to new facts of Value in Health, the newer antipsychotic Zyprexa (Olanzapine) may not result in cost savings comparing with an older, inexpensive generic antipsychotic in treating of schizophrenia disease. It was revealed that despite higher medication costs of Zyprexa tablets the difference in one-year direct total costs between this [...]
